Lower riskMedical device recall · FDA · Published December 23, 2020
BD Hypodermic Syringe 10ml Risk: Open Packaging May Compromise Sterility
Becton Dickinson recalls 10ml eccentric tip syringes with open seals that could compromise sterility. Affected units have catalog number 305482 and expire May 2023. Consumers should check packaging for open seals.
The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe.
Take action
Contact the company
📍Recalling firmBecton Dickinson & Company1 Becton Dr · Franklin Lakes, NJ 07417-1815
“BD Hypodermic Syringe 10ml Risk: Open Packaging May Compromise Sterility.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63621-bd-hypodermic-syringe-10ml-risk-open-packaging-may-compromise-sterility. Based on FDA recall #Z-1109-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1109-2021%22&limit=1).
The FDA announced on Dec. 23, 2020, that Becton Dickinson & Company voluntarily recalled BD Hypodermic Syringes with eccentric tips due to open seals that may compromise sterility. The recall involves 155,200 units distributed nationwide in the U.S. and Canada.
How to tell if you have it
Brand: Becton Dickinson
Product: BD Hypodermic Syringe 10 ml, eccentric tip
Catalog (Ref No.): 305482
Lot #: 8142303
Expiration date: 31-May-2023
UDI: 00382903054824
The hazard
The product packaging for the 10 ml eccentric tip syringe may exhibit open seals. An open seal impacts package integrity and potentially compromises sterility of the syringe.
Context
GovInfoNow's records show Becton Dickinson & Company has 52 other recalls on record since May 31, 2017. Other recent recalls include a Jan. 27, 2026 recall of 10mL Non-Sterile Luer-Lok Syringes due to wrong syringe type and an Oct. 14, 2025 recall of Luer Tip Caps for failed biocompatibility testing. Similar product recalls include Dec. 24, 2025 Medline Sterile Resuture Pack Kits, Medline Anesthesia Artline Packs, and Medline Medical Kits, all citing open seal risks.
How to tell if you have this one
Check for open seals on the packaging. Affected syringes have catalog number 305482 and expire May 2023. The product was sold with lot number 8142303.
Brand
Becton Dickinson
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Packaging Seal
Inspect the syringe packaging for open seals. If the seal is broken, the syringe may not be sterile.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Distribution US nationwide and Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 23 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1109-2021 (December 23, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1109-2021 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.